In Brief
Belin et al. used comparative proteomics approaches and revealed a signaling network of injury responses in axotomized retinal ganglion cells and also demonstrated c-myc as a critical regulator of neuronal survival and axon regeneration.
INTRODUCTION
In the adult mammalian CNS, axotomy often triggers neuronal death, and spontaneous axon regeneration rarely occurs. An implicated mechanism is the diminished intrinsic regenerative ability of mature CNS neurons (Fawcett, 2006; Goldberg et al., 2002b; Moore et al., 2009; Park et al., 2008) . Based on the differences in axon growth between immature and mature neurons, it has been proposed that the neuronal intrinsic growth ability is lost over the course of development. Therefore, much effort has been made to seek molecular pathways that are differentially expressed during development and in the adult, resulting in the identification of several axon regeneration regulators. For example, in many types of neurons, cAMP levels appear to be higher in the immature neurons, but decline in the mature neurons (Cai et al., 2001; Filbin, 2003) . By analyzing the axon growth of retinal ganglion cells (RGCs) from different developmental stages, Goldberg et al. showed a development-dependent decline of axon growth rate, with a dramatic decrease in postnatal RGCs (Goldberg et al., 2002a) . Further, recent studies implicated transcription factors from the Krü ppel-like family of transcription factors (KLFs) as critical regulators of development-dependent axon growth ability in RGCs (Moore et al., 2009) . Interestingly, while KLF7 is downregulated, other members, such as KLF4, are upregulated during development. Importantly, manipulations of these factors could promote the regrowth of injured optic nerve axons and corticospinal tract axons in the adult (Blackmore et al., 2012) .
However, ample evidence indicates that even in the adult CNS, many uninjured neurons possess considerable capacity for structural plasticity and collateral sprouting (Holtmaat and Svoboda, 2009; Raineteau and Schwab, 2001) . For example, upon incomplete spinal cord injury in the adult, spared axons have been repetitively shown to elaborate spontaneous sprouting responses (Bareyre et al., 2004; Rosenzweig et al., 2010) . Furthermore, such sprouting responses could be further enhanced by rehabilitation training (Harel et al., 2013; van den Brand et al., 2012) . This is in contrast to no or limited regrowth from injured axons in the adult CNS (Bradke et al., 2012; Goldberg et al., 2002b; Moore et al., 2009; Park et al., 2008; Rossi et al., 2007) . Therefore, it is possible that in addition to development-dependent processes, axonal injury-triggered stress responses might contribute to the impaired intrinsic regenerative ability of mature neurons.
While many previous studies documented gene expression changes in different types of injured neurons (Costigan et al., 2002; Michaelevski et al., 2010; Saul et al., 2010; Tanabe et al., 2003; Fischer et al., 2004) , pinpointing key molecular pathways that orchestrate neuronal survival and axon regeneration remains a major challenge. One possible reason is that axotomy may impinge on both gene transcription as well as protein translation and degradation. Thus, analyzing the transcriptome may not reflect the full scope of injury-induced changes in neurons.
As protein abundance is the final readout of gene expression, translation, and degradation, analyzing injury-induced changes in protein abundance may provide a direct assessment of neuronal injury responses. Although proteomic methods have been used extensively for the analyses of cultured cells and whole tissues (Chen and Springer, 2009; Kim et al., 2014; Magharious et al., 2011; Wilhelm et al., 2014) , very few studies have utilized procedures to analyze a specific type of primary neurons purified directly from live tissue. In this study, we performed a quantitative proteomics experiment to profile changes in protein abundance in RGCs induced by optic nerve injury relative to an uninjured control. Subsequent informatics analyses identified a set of injury-response pathways that have an impact on the intrinsic growth ability and regenerative responses after injury.
RESULTS

Quantitative Proteomic Analysis of Intact and Injured RGCs
As an optic nerve injury transects the axons from all RGCs in the retina, it is an ideal model for isolating homogenously injured neurons and analyzing their injury responses. This is further facilitated by the availability of the transgenic mouse line YFP-17 (Sun et al., 2011) , in which the yellow fluorescent protein (YFP) is predominantly expressed in the RGCs and in a few amacrine cells ( Figure S1A ). Using these YFP-17 mice, we performed an optic nerve injury on one eye of these animals and left the other eye uninjured as control. At 3 days post-injury before extensive apoptotic death has occurred, axotomized and intact retinas were dissected out, and dissociated cells were subjected to fluorescence-activated cell sorting (FACS) purification.
FACS gating parameters were optimized to select cells based on size, viability (DAPI-negative cells), and YFP+ signal (Figure 1A) and resulted in the isolation of 99% viable YFP+ cells ( Figure S1B ). In this experiment, the isolation of a subset of neurons, i.e., predominantly RGCs, results in the specific analysis of the injury response to the optic nerve. We collected three biological replicate samples, each of which consists of a pool of injured or control RGCs (15 retinas per pooled replicate corresponding to 1.5 3 10 6 cells). Samples were lysed, and total protein concentrations were measured for the lysates using BCA. Equal amounts of protein from individual samples were digested using trypsin, and the resultant peptides were labeled with one of the six tandem mass tags (TMTs). These samples were then mixed and fractionated using isoelectric focusing. Less than 10 mg from each fraction was subjected to LC-MS/MS analysis using the standard methods and Pulsed-Q dissociation (PQD) to quantify the TMT reporter ions on an Orbitrap Classic instrument (Griffin et al., 2007; Thompson et al., 2003) . The resulting spectra were searched with MASCOT (v2.1) against an annotated mouse protein database (IPI 3.68) to identify spectral matches to annotated peptides. These matched spectra (peptide spectral matches, PSMs) corresponded to 7,514 unique peptides and were grouped into 1,409 proteins using a 1% false-discovery rate (FDR) cutoff and a minimum of two peptides per protein (Figure 1C ; Table S1 ). Proteins were identified from a range of subcellular compartments, such as the cytoplasm (60%), nucleus (18%), and plasma membrane (14%), and functional classes, such as kinases/phosphatases, transcriptional regulators, or ion channels. This result indicates that a broad functional depth of the proteome was measured ( Figure S2 ; Table S2 ). Protein abundance was analyzed in a pairwise fashion within biological samples of RGCs with injured optic nerves and their control RGCs from uninjured optic nerves from the same animals and plotted as the ratio of expression in the injured sample divided by expression in the control (log 2 scale), revealing that the majority of identified proteins showed similar abundance values before and after injury ( Figure 1D ). Interestingly, 62 proteins were significantly increased or decreased, respectively, in the injured RGCs compared to the uninjured control ( Figure 1D ; Table S2 ).
Functional Annotation of Injury-Altered Proteins Next, we used Ingenuity Pathway Analysis (IPA) to assess which cellular functions might be related to these 62 altered proteins that are affected in the injury response. As shown in Figure 2A and Table S3 , most downregulated proteins appear to be associated with cellular functions such as formation of cellular protrusions, organization of cytoskeleton, and microtubule dynamics. Since these processes represent critical steps of axon regeneration, these changes might reflect the reduced intrinsic regenerative ability of injured RGCs.
Putative Key Regulators of Injury Responses Revealed by Informatics Analysis
We reasoned that such protein abundance alterations might reflect the outcomes of injury response-signaling events. Therefore, we subjected these 62 proteins to an IPA-based network analysis (Staab et al., 2007) in order to find major signaling events occurring in axotomized RGCs. This analysis revealed nine signaling networks ( Figure S2C ; Table S4 ) and relevant signaling hubs ( Figure S2C ). The top 12 signaling hubs are listed in Figures  2B and 2C . Strikingly, this list includes several known regulators of neuronal survival and axon regeneration, such as TP53, Ca 2+ (Ghosh-Roy et al., 2010; Chierzi et al., 2005; Sung et al., 2001; Bradke et al., 2012) , MAPK Hammarlund et al., 2009; Watkins et al., 2013) , JAK (Smith et al., 2009; Sun et al., 2011) , and the components of mTOR pathway, such as Rictor, Raptor, and mTOR (Dupraz et al., 2013; Liu et al., 2010; Near et al., 1992; Park et al., 2008; Toth et al., 2006; Zhu et al., 2010) , validating the use of this approach in analyzing neuronal injury responses. Interestingly, this list also includes several other molecules, such as c-myc, Huntingtin (HTT), and NFkB ( Figures 2B and 2C ), which might represent new candidates for critical regulators of the neuronal injury response.
c-myc Expression Is Downregulated in RGCs in
Response to Injury Our further analysis has been focused on c-myc, which was one of the most connective nodes of the regulator network ( Figures  2B and 2C ; Table S4 ). c-myc was not among the 1,409 proteins identified by proteomics analysis (Tables S1 and S2), possibly due to its low protein abundance in adult RGCs. However, among 62 injury-altered proteins identified from our proteomics analysis, ten proteins (highlighted in red in (B) A schematic of the multiplexed quantitative proteomics workflow. Retinas from uninjured YFP17 mice (noted WT, wild-type) and from YFP17 mice 3 days post optic nerve crush (WTc) were collected (i). After dissociation, YFP + neurons were purified by FACS (ii). Three independent biological replicate samples were collected for each condition (each sample from at least 15 retinas) and subjected to cell lysis (iii) and tryptic digestion (iv). Samples were then labeled with specific mass-coded TMT tags (illustrated with different colors) prior to mixing (v), OFFgel fractionation (vi), LC-MS/MS, and informatics analyses to identify and quantify peptide spectrum matches (PSMs) (vii-x).
(C) Table of functional interactions with c-myc in the network. Importantly, similar to mTOR (Howell et al., 2013; Laplante and Sabatini, 2012; Shaw and Cantley, 2006) , c-myc has been implicated as a master control gene of cellular metabolism (Dang, 2013) , positioning it as an excellent candidate to improve RGCs survival and axon regeneration. To verify the involvement of c-myc in the injury response, we examined the expression level of c-myc before and after injury. Using real-time qPCR analysis of mRNA purified from samples subjected to identical treatments as in the proteomics experiments (Figure 1 ), we observed that the expression of c-myc mRNA is decreased by 70% after injury ( Figures 3A and 3B ). This injury-induced c-myc downregulation was also verified by immunohistochemistry with anti-c-myc antibodies on retinal sections from intact and injured mice ( Figure 3C ). These results together verified the injury-induced c-myc downregulation in injured RGCs.
Overexpression of c-myc in RGCs Promotes Axon Regeneration In Vivo
We next assessed the effects of c-myc overexpression on neuronal responses by two different approaches. First, as we demonstrated previously, injection of adeno-associated virus serotype 2 (AAV2) vectors into the vitreous body results in highly selective and efficient transduction to RGCs (Park et al., 2008; Sun et al., 2011) , thus we injected AAV2 expressing c-myc or a control placenta alkaline phosphatase (PLAP) into the vitreous body of adult mice. These mice were then subjected to a standard optic nerve injury procedure, followed by a cholera toxin B subunit (CTB) injection to analyze neuronal survival and axon regeneration (Park et al., 2008) . At 2 weeks post-injury, we observed that 49% of RGCs survived in c-myc-overexpressing mice, whereas only 25% survived in the mice injected with AAV2-PLAP ( Figures S3A and S3B ). Importantly, a significant axonal growth increase was observed in the optic nerves from c-myc-overexpressing mice ( Figures S3C and S3D ), suggesting that c-myc overexpression could promote both neuronal survival and axon regeneration after injury.
As an independent approach to assess the effect of c-myc overexpression, we used an inducible c-myc transgenic mouse line, ROSAMER mice (Jä ger et al., 2004) . In these mice, a cassette with the gene encoding a tamoxifen-inducible c-mycERT fusion protein (mycERT) downstream of a lox-stop-lox sequence was inserted in the ubiquitously active ROSA26 locus. Therefore, mycERT transcription is Cre dependent, and the activity of the fusion protein is tamoxifen inducible. We then tested the effect of a transient activation of c-myc prior to injury. After the intravitreal injection of AAV2-Cre or AAV2-PLAP, and subsequent tamoxifen induction, these mice were subjected to optic nerve injury ( Figure 3D ). As shown in Figures 3E-3G , both robust neuronal survival and axon regeneration were observed in the mice injected with AAV2-Cre, but not with control AAV2-PLAP. The extent of the regenerative response was comparable to that observed in PTEN-deleted mice (Park et al., 2008) . These phenotypes are more robust than what was observed after AAV2-c-myc expression ( Figure S3 ), possibly due to a more efficient expression of c-myc in these transgenic mice. We also monitored the mTOR activity in RGCs under these treatments, 3 days after injury, by immunohistochemistry using antibodies against phosphorylated-ribosome protein S6 (P-S6), an established indicator of the mTOR activity (Guertin and Sabatini, 2007) . As shown in Figure S4 , RGCs with c-myc overexpression still exhibited significant injury-induced mTOR downregulation, although the extent of downregulation is less than that observed for the controls. These data further support the notion that c-myc overexpression is able to promote RGC axon regeneration after optic nerve injury.
Delayed c-myc Overexpression Still Promotes Optic Nerve Regeneration
To mimic clinically relevant settings, we assessed the effects of expressing c-myc after a delayed post-injury period. We thus administered tamoxifen to ROSAMER mice starting from 1 day after optic nerve injury ( Figure 4A ). At 2 weeks post-injury, we observed that approximately 55% of RGCs survived, in comparison with 25% in controls ( Figures 4D and 4E ). In addition, significant numbers of regenerating axons were observed in the animals with delayed c-myc expression with many regenerating axons growing beyond the injury site and extending 1.5 mm from the crush site ( Figures 4B and 4C ). As the apoptotic pathways might be activated at these axotomized RGCs (Figure 2 ), our results suggest that c-myc can rescue these injured neurons from apoptotic death and promote their axon regeneration.
c-myc Is Essential for Regenerative Phenotype of PTEN Deletion
The experiments above implicated injury-induced c-myc downregulation as an important mechanism reducing the intrinsic regenerative ability of adult RGCs. We then investigated whether c-myc is required for axon regeneration in adult RGCs induced by other manipulations. Since PTEN inhibition was previously shown to activate mTOR and promote neuronal survival and axon regeneration Park et al., 2008; de Lima et al., 2012) , we thus examined whether a genetic knockout of c-myc might affect the axon regeneration induced by shRNAmediated PTEN silencing (Zukor et al., 2013) . We co-injected AAV2-ShPTEN with AAV2-Cre or AAV2-PLAP into the vitreal body of the c-myc f/f mice and performed optic nerve injury after 4 weeks. As expected, PTEN silencing by shRNA resulted in significant axon regeneration as analyzed at 2 weeks post-injury ( Figures S5A and S5B ). The knockout of c-myc significantly reduced the numbers of regenerating axons ( Figures S5A and  S5B ), but did not affect neuronal survival ( Figures S5C and  S5D ) or the mTOR activity ( Figure S5E ). However, some residual regenerating axons were still observed after c-myc deletion (Figures S5A and S5B) . It remains unclear whether this result reflects the differential involvement of c-myc in RGC subtypes or the compensatory effects of other myc members.
Synergistic Effects of c-myc Overexpression and PTEN and SOCS3 Deletion Our systems biology analyses of the pathways involved in the neuronal response to injury strongly suggest that other major signaling hubs work in concert with c-myc ( Figures 2B and  2C ). To better understand their functional interactions, we analyzed the combinatorial effects in the optic nerve injury model by manipulating both c-myc and the mTOR pathway, which was also implicated by the network analysis (Figure 2) . Thus, we performed an intravitreal co-injection of AAV2-Cre, together with AAV2-c-myc or AAV2-PLAP, in PTEN f/f mice ( Figure 5A ). At 2 weeks after injury, we observed significant increase in neuronal survival and axon regeneration in the PTEN f/f mice with c-myc expression with around 75% of RGCs alive ( Figures 5B-5D ).
As our previous studies showed robust axon regeneration after co-deletion of PTEN and SOCS3 in RGCs (Sun et al., 2011) , we further examined the effects of this co-deletion in combination with c-myc overexpression ( Figure 6A ). Thus we performed an intravitreal co-injection of AAV2-Cre and AAV2-CNTF, together with AAV2-c-myc or AAV2-PLAP, in PTEN f/f /SOCS3 f/f mice. As shown in Figure 6B , such a combinatorial treatment resulted in further-enhanced axon regeneration. At 4 weeks post-injury, about 5 times more regenerating axons reached the proximal end of the chiasm when compared with PTEN/ SOCS3 deletion alone ( Figures 6B, 6C , and S6). In the mice with PTEN/SOCS3 co-deletion, the majority of regenerating axons ceased growing in the proximal end of the chiasm (Luo et al., 2013; Sun et al., 2011) . However, with additional c-myc expression, while some axons grew ectopically into the contralateral optic nerve, many more axons crossed the chiasm and continued to grow in the optic tracts, with some ipsilaterally, and more contralaterally ( Figures 6B and 6E ). After crossing the chiasm, many regenerating axons derail from the optic tract, similar to the results shown by Luo et al., 2013 . At 8 weeks postinjury, while most of regenerating axons disappeared in the mice with PTEN/SOCS3 deletion without c-myc expression, many regenerating axons remained in the mice with triple treatment (Figure S7 ). In these animals, however, the numbers of regenerating axons are reduced to some extent ( Figure S7 ), possibly due to the elimination of regenerating axons that have not formed proper synaptic connections. These results suggested that comanipulation of these injury-response pathways could result in a synergistic effect on promoting neuronal survival and axon regeneration.
Differential Injury Responses in RGCs and DRG Neurons
As the neurons in the PNS and the CNS differ in their regenerative ability, we examined how these injury-regulatory pathways are differentially regulated in regeneration-competent DRG neurons. As shown in Figure 7 , the c-myc expression level, measured by qPCR with the mRNA samples from DRGs, was significantly increased at 1 day post-injury, but returned to the basal levels from 3 days post-injury. Consistent with the regulation of cmyc transcripts, the protein abundance of c-myc as measured using anti-c-myc antibodies showed delayed increase at 3 days post-injury ( Figure 7B ). In addition, we also monitored the mTOR activation levels by immunohistochemistry with antiphospho-S6 antibodies. As shown in Figure 7C , the phospho-S6 is significantly increased in DRG neurons with a sciatic nerve injury, in contrast to the injury-induced mTOR downregulation observed in RGCs (Figures 2 and S6 ; Park et al., 2008) . These results revealed a correlation between the activation levels of these pathways and the neuronal regenerative ability, suggesting the critical roles of these and other identified injury-responsive molecules in determining the intrinsic regenerative ability in mature neurons.
DISCUSSION
By using a systems biology analysis of protein abundance changes measured by quantitative mass spectrometry followed by bioinformatics analyses, we identified a network of molecular pathways that are altered in injured RGCs. Manipulations of two of these pathways, myc and mTOR, resulted in dramatically increased neuronal survival and axon regeneration. Although the combined effects with other pathways remain to be tested, these results suggest the possibility that manipulation of these injury-response pathways simultaneously might represent a powerful strategy for promoting neuronal survival and axon regeneration. While it has been proposed that the intrinsic regenerative ability is a critical determinant of axon regeneration, its molecular signatures and its regulatory mechanisms remain poorly understood. Our results provide mechanistic evidence for the hypothesis that injury-triggered stress responses might be important to the loss of intrinsic regenerative ability observed in the adult RGCs. The major injury-altered signaling pathways identified in this study could be strong potential molecular determinants, which might play different roles in regulating the intrinsic capacity to regenerate upon injury. For example, the components of the MAPK pathway were found on the list of the identified injury-response pathways, consistent with ample evidence supporting MAPK activation as an evolutionarily conserved injury signal Hammarlund et al., 2009; Watkins et al., 2013) . Similarly, the current studies point to a critical role for injury-triggered responses in downregulating the mTOR activity, an implicated player in regulating neuronal survival and axon regeneration after injury Park et al., 2008; Sun et al., 2011) . In addition, our analysis also reveals a number of novel putative injury-response molecules, such as c-myc, NFkb, and HTT, which might provide new avenues of exploration to understand the molecular mechanisms of intrinsic regenerative ability. Our further analysis on c-myc provides compelling evidence verifying the role of such novel molecular players in neuronal injury responses. Forced expression of cmyc in RGCs, either before or after injury, promotes neuronal survival and axon regeneration, and this effect is further amplified by the combined deletion of PTEN and SOCS3. Importantly, both c-myc and mTOR are differentially regulated in regeneration-competent peripheral sensory neurons, suggesting a possibility that the role of these molecules in affecting the intrinsic regenerative ability might not be limited to a single neuronal type.
How c-myc acts in injury responses remains unclear. c-myc is described as being a master transcription factor that regulates genes involved in different aspects of anabolic metabolism, such as ribosome biogenesis, lipid synthesis, nucleic acid synthesis, intermediary metabolism, and cell growth and proliferation (Dang, 2013) . Our data suggest that the activity of c-myc is a key step toward achieving successful axon regeneration after an injury to override a shift in metabolic state that usually results in the degeneration of axons and eventual apoptosis. This is especially important for the mature neurons in the adult, because in these resting cells the ATP is mainly generated by catabolic processes and is used to maintain energy-costly homeostatic processes, such as cytoskeletal functions and ion and nutrient transport. However, for an injured neuron to initiate regenerative growth, it has to shift toward anabolic processes, allowing for the de novo synthesis of macromolecules from available nutrients. In fact, mTOR has also been implicated as an important regulator of cell metabolism, because it can alter cellular metabolism to drive the biosynthesis of building blocks and macromolecules essential for cell growth (Guertin and Sabatini, 2007; Xie and Proud, 2013) . Therefore, a plausible model is that c-myc alone or together with mTOR might allow injured neurons to achieve such a shift of metabolic states for axonal regrowth. It would also be interesting to test whether other metabolic modulating methods could alter neuronal regenerative ability. On the other hand, recent studies documented an increase in c-myc protein in the promoter region of active genes as opposed to regulating the expression of specific genes, thus amplifying the overall output of the existing gene expression program in tumor cells (Lin et al., 2012; Nie et al., 2012) . Thus, an alternative model is that c-myc might act similarly in neurons by boosting the general gene expression, which may explain its dramatic effect on increasing the regeneration observed in combination with the PTEN/SOCS3 deletion. Understanding how these and other pathways act in neuronal injury responses holds promise in identifying new targets for designing new strategies to promote neuronal survival and axon regeneration. The identification of injury-response networks by systemswide approaches as used in this study may also provide an example for investigating the pathogenesis of other types of neurological diseases, because how different types of neurons respond to specific stress conditions remains an unsolved mystery. For example, the abnormal expression of pathological proteins, such as amyloid-b or mutant superoxide dismutase 1 (SOD1), might be critical for the development of Alzheimer's disease or amyotrophic lateral sclerosis. In these cases, despite the ubiquitous expression of pathological proteins in all cell types, often only subtypes of neurons exhibit pathological alterations and neuronal loss, suggesting that similar to injury responses, neurons may differ in their responses to other types of stress conditions. It therefore will be valuable to analyze the stressresponse programs in individual neuronal types and to test whether similar or different stress-response programs are activated in other pathological conditions, and manipulating such pathways could be beneficial.
EXPERIMENTAL PROCEDURES
Surgical Procedures
All experimental procedures were performed in compliance with animal protocols approved by the IACUC at Boston Children's Hospital. For all surgical procedures, mice were anesthetized with ketamine and xylazine. Eye ointment containing atropine sulfate was applied to protect the cornea during surgery. Animals received buprenorphine for 24 hr as a post-operative analgesic. line is mixed. This mouse line has been previously described (Sun et al., 2011) . AAV2 Virus Injection C57BL6/J mice (used as wild-type controls), PTEN f/f mice, and Rosamer-myc mice were injected intravitreally (to their right eyes) with 1.5 ml of AAV2-Cre, AAV2-myc, AAV2-CNTF, AAV2-ShPTEN, or AAV2-PLAP (titers around 1 3 10 12 ). PTEN f/f /SOCS3 f/f mice (Sun et al., 2011) were injected first with AAV2-Cre and AAV2-CNTF and then AAV2-PLAP or AAV2-c-myc. For each injection, a glass micropipette was inserted to peripheral retina, behind ora serrate to avoid damage to the lens.
Mouse Lines
Optic Nerve Injury
At 2 weeks or 4 weeks for AAV2-ShPTEN following the AAV2 injection, the right optic nerve was exposed intraorbitally and crushed with forceps (Dumont #5, Fine Science Tools) for 5 s approximately 1 mm behind the eye ball, as previously described (Park et al., 2008; Sun et al., 2011) .
RGC Anterograde Labeling
At 3 days before termination, 1.5 ml of CTB conjugated to Alexa 488 (2 mg/ml, Invitrogen) was injected into the vitreous chamber with syringe (Hamilton) to label axons in optic nerve. All tissues were processed as described previously (Park et al., 2008; Sun et al., 2011) .
Sciatic Nerve Crush
The right sciatic nerve was exposed and crushed with forceps (Dumont #5, Fine Science Tools) for approximately 20 s.
Axon Regeneration Quantification
Number of regenerating axons in the optic nerve was estimated by counting the number of CTB-labeled axons at different distances from the crush site as described previously (Park et al., 2008; Sun et al., 2011) .
Immunohistochemistry
Sections or whole-mount retinas were incubated overnight at 4 C with primary antibodies: Tuj1 (1/400, Covance), P-S6 (1/200, Cell Signaling Technology), NeuN (1/100, Millipore), and c-myc (1/200, Abcam) diluted in PBS, BSA (3%) Triton X-100 (0.5%) as described in Nawabi et al. (2010) . Then, tissues were incubated for 2 hr at room temperature with appropriate Alexa Fluor conjugate secondary antibodies (Alexa 488, Alexa 594, Alexa 674; Invitrogen) diluted with the same blocking solution as the primary antibodies. Sections or whole-mount retinas were mounted with DAPI-Fluoromont-G (Solulink).
RGCs Survival and Phospho-S6 Signal
Tuj1-positive cells in the ganglion layer were counted using a fluorescent microscope after immunostaining whole-mount retinas with anti-Tuj1 antibodies. A total of eight random fields per retina were enumerated. The average number per field was determined, and the percentages of viable RGCs were obtained by comparing the values determined from the uninjured contralateral retinas. In the same condition, after phospho-S6 staining, the densities of phopsho-S6-positive RGCs were obtained by comparing the value from the uninjured contralateral retinas.
Whole-Mount Optic Nerve Preparation
Optic nerves were prepared as described in Dodt et al. (2007) . Briefly, optic nerves were post-fixed overnight at 4 C in PFA 4%, then dehydrated in ethanol (50%, 80%, and 95% for 20 min each). Optic nerves were incubated for 1 hr in ethanol 100% and then 2 hr in hexane (Sigma). Finally, samples were transferred in benzyl benzoate/benzyl alcohol (2:1 in volume; Sigma) clearing solution.
Imaging
Optic nerves from different experiments (sections and whole mount) were imaged using a spinning disk confocal microscope (Zeiss) with Velocity software (PerkinElmer). A 203 objective was used to acquire image stacks with a 2-mm z spacing and 20% overlap in the (x;y) dimensions. The motorized stage enables the automation of the imaging procedure. All the images were then stitched together using the Velocity software and z-projected to maximal intensity for quantification. Whole-mount retinas were imaged with a Nikon 80i epifluorescence microscope with 203 objective. At least eight random fields were imaged per retina.
Statistical Analysis
One-way ANOVAs were performed using PRISM software, and specific differences between groups were confirmed with Bonferroni t test. When two groups were compared, t test was used.
FACS Analysis
YFP-17 mice were subjected to optic nerve injury. At 3 days after injury, animals were euthanized, and injured or intact retinas were immediately dissected out for dissociation. Retinas were collected in 800 ml HBSS supplemented with trypsin (5 mg/ml) and DNase (0.2 mg/ml) for 10 min at 37 C.
Retinas were washed three times with DMEM/10% FBS and dissociated mechanically using a P1000 pipetman. Cells were pelleted by centrifugation for 5 min at 200 3 g suspended in Neurobasal supplemented with L-glutamine and B27 plus DAPI (1 mg/ml) and filtered through a 40-mm cell strainer (BD Falcon) before FACS sorting. FACS sorting was performed with a BD FACSAria IIu instrument. Prior to each sorting event, a purity test was performed to ensure that the specificity for the YFP signal was higher than 99%. Dissociated retinal cells were separated based on size (forward scatter) and surface characteristics (side scatter) as well as viability (DAPI staining). Aggregated cells were excluded based on the FSC-H-versus-FSC-A ratio. Retinal cells without YFP expression were used as negative controls to optimize the detection gate prior to each sorting. Sorted cells were immediately subjected to either proteins or RNA extraction.
Quantitative Proteomics Analysis of RGC Cells from each preparation were immediately lysed using Qproteome mammalian buffer, and proteins were precipitated using chloroform/methanol. Protein (100 mg) from each sample was reduced with tris(2-carboxyethyl) phosphine (TCEP) and alkylated with a 0.05 M iodoacetamide solution in the dark at room temperature (23 C) for 20 min. A proteolytic digestion was carried out with trypsin at 37 C for 16 hr. Labeling reagents from the TMT 6-plex Isobaric Label Reagent Set (PI-90064, Thermo Fisher Scientific) were added to the peptide samples and incubated at room temperature for 1 hr. The reaction was quenched by adding 8 ml of 5% hydroxylamine to the samples, incubated at room temperature for 1 hr and combined together. Peptides were eluted from the spin columns. After acidification, the peptides were desalted on an OASIS HLB column (Waters) and evaporated to dryness, prior to isoelectric focusing fractionation according to their isoelectric point. Resultant peptide fractions were dried before re-suspension in MS loading buffer (5% acetonitrile, 0.1% formic acid in H 2 O). Less than 10 mg of each fraction was analyzed by nano-LC-MS/MS using a 60-min gradient. PQD on the LTQ Orbitrap Classic was used to fragment the peptide precursor ions. Thermo RAW files were processed using an in-house informatics pipeline (Bigbang/Horizon) and searched with a MASCOT (version 2.1) search engine against the IPI mouse protein database (IPI 3.68) using a target-decoy database to calculate the FDR. TMT 6-plex modifications were set as dynamic modifications in the database search and as static modifications for all other data analysis. This allowed us to calculate labeling efficiencies-the labeling efficiency for our experiments was 98.73%. All PSMs used in this analysis had a MASCOT score above 32 and q value below 0.01. Only proteins identified with a high rate of confidence (1% FDR) were used for analysis. Functional analysis was performed using IPA (Ingenuity Systems). The extended methods are described in Supplemental Information.
RNA Extraction
Cells were immediately lysed using a TRIzol reagent (Invitrogen), and RNA was purified using the RNeasy RNA extraction kit (QIAGEN). Total RNA (50-100 ng) was reverse-transcribed and amplified with real-time PCR assays using iQ SYBR Green (Bio-Rad). Real-time PCR was performed on a Bio-Rad CFX 96. Each sample was run four times in each assay. GADPH was used as the endogenous control. 
SUPPLEMENTAL INFORMATION
